Diabetes Devices Market Share

ID: MRFR/HC/10767-HCR

134 Pages

Kinjoll Dey

October 2025

Diabetes Devices Market Research Report By Device Type (Blood Glucose Monitors, Insulin Delivery Devices, Continuous Glucose Monitoring Systems, Diabetes Management Software), By End User (Hospitals, Homecare, Diabetes Clinics, Ambulatory Surgical Centers), By Distribution Channel (Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Direct Sales), By Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Share

Diabetes Devices Market Share Analysis

In the dynamically changing health care technology today, the global diabetes devices market is at a turning point, and there are unique strategies used by different market players for retaining and expanding market share. One crucial positioning strategy for market share is ongoing progress of glucometers since the time they first come out. The businesses in this field are aiming to build the latest technology sensors which provide Live status updating, improved accuracy and easy-to-work with devices. This approach is made to uphold the competitive edge and the fact that the patients and healthcare professionals will prefer the device that understands their needs and offers the most accurate data while at the same time giving them an enjoyable experience.

Companies in the Diabetes Devices Market are centering their shares positioning strategies around collaborations and partnerships which are critical elements. In addition, businesses make partnerships with health suppliers, mobile app developers, and other participants to provide complete diabetes management systems. Through enabling product devices to connect to digital platforms, manufacturers enhance functionality of products making it possible for sharing of data, and leading to the provision of more precise and efficient diabetes management. Building strategic partnerships not only suppliers additional item to the range of products provided, but also put companies to the frontline in the chain of managing diabetes around the world.

Additionally, a people-oriented or customer-centric strategy is one key to forming the fight for market share. The OEMs with better user experience make sure that though the devices technical are advanced, they are also simple to use and harmonize with the individual routines. Empower collaboration with physicians and improving patient satisfaction are the key areas in diabetes management which require healthcare companies to carefully take into consideration the specific requirements of their users. Where customers receive high levels of satisfaction as a result, this not only influences their initial adoption but also creates the environment for long-term brand loyalty, speeding growth in market share.

Focusing on the therapeutic specialization follows as another important sales strategy in terms of Diabetes medical devices market share. On the other hand, companies usually put an emphasis on a particular field of diabetes management, such as insulin systems or continuous glucose monitoring. Via this narrowing the scope, corporations have a knack of skillful employment, resulting in the market leaders in the selected niche markets. For instance, a company manufacturing smart insulin delivery systems may be selling itself to the population as the best in insulin mistreatment, therefore taking a big market share in this niche alone.

Market Highlights

Author

Kinjoll Dey

Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

FAQs

What is the projected market valuation of the Diabetes Devices Market by 2035?

The Diabetes Devices Market is projected to reach a valuation of 75.13 USD Billion by 2035.

What was the market valuation of the Diabetes Devices Market in 2024?

In 2024, the market valuation of the Diabetes Devices Market was 32.88 USD Billion.

What is the expected CAGR for the Diabetes Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Diabetes Devices Market during the forecast period 2025 - 2035 is 7.8%.

Which segment of diabetes devices is projected to have the highest growth by 2035?

The Insulin Delivery Devices segment is projected to grow from 10.0 USD Billion in 2024 to 25.0 USD Billion by 2035.

How do the revenues of Type 2 Diabetes devices compare to Type 1 Diabetes devices?

Type 2 Diabetes devices are projected to generate revenues of 20.0 USD Billion in 2024, significantly higher than the 5.0 USD Billion for Type 1 Diabetes devices.

What are the key players in the Diabetes Devices Market?

Key players in the Diabetes Devices Market include Medtronic, Abbott, Roche, Johnson & Johnson, and Dexcom.

Which distribution channel is expected to see the most growth by 2035?

Retail Pharmacies are expected to grow from 10.0 USD Billion in 2024 to 25.0 USD Billion by 2035.

What is the projected revenue for Continuous Glucose Monitoring Systems by 2035?

Continuous Glucose Monitoring Systems are projected to reach revenues of 22.0 USD Billion by 2035.

How does the market for diabetes management software compare to other device types?

Diabetes Management Software is expected to grow from 4.88 USD Billion in 2024 to 10.13 USD Billion by 2035, indicating a steady increase.

What is the anticipated revenue for homecare diabetes devices by 2035?

Homecare diabetes devices are anticipated to generate revenues of 28.0 USD Billion by 2035.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Diabetes Devices Market was estimated at 32.88 USD Billion in 2024. The Diabetes Devices industry is projected to grow from 35.44 USD Billion in 2025 to 75.13 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.8 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Diabetes Devices Market is experiencing robust growth driven by technological advancements and increasing patient awareness.

North America remains the largest market for diabetes devices, reflecting a strong demand for innovative solutions. The Asia-Pacific region is identified as the fastest-growing market, propelled by rising diabetes prevalence and healthcare investments. Blood glucose monitors continue to dominate the market, while continuous glucose monitoring systems are rapidly gaining traction. Key market drivers include the rising prevalence of diabetes and technological innovations in diabetes management.

Diabetes Devices Market

CAGR

7.8%

Market Size & Forecast

2024 Market Size	32.88 (USD Billion)
2035 Market Size	75.13 (USD Billion)
CAGR (2025 - 2035)	7.8%
Largest Regional Market Share in 2024	North America

Major Players

<a href="medtronic.com/en-us/healthcare-professionals/products/diabetes.html">Medtronic </a>(US), Abbott (US), Roche (CH),<a href="https://innovativemedicine.jnj.com/canada/our-focus/cardiovascular-metabolic/diabetes"> Johnson & Johnson </a>(US), Dexcom (US), Boehringer Ingelheim (DE), Insulet (US), Ascensia Diabetes Care (DE), AstraZeneca (GB)

Market Trends

The Diabetes Devices Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing prevalence of diabetes worldwide. Innovations in continuous glucose monitoring systems and insulin delivery devices are reshaping how patients manage their condition. These devices not only enhance patient convenience but also improve health outcomes by providing real-time data and personalized treatment options. Furthermore, the integration of digital health solutions, such as mobile applications and telemedicine, is facilitating better patient engagement and adherence to treatment protocols. In addition to technological advancements, the market is influenced by a growing awareness of diabetes management among healthcare professionals and patients alike. Educational initiatives and support programs are becoming more prevalent, encouraging individuals to take proactive steps in managing their health. This shift towards a more informed patient population is likely to drive demand for innovative diabetes devices, as individuals seek tools that empower them to monitor and control their condition effectively. As the Diabetes Devices Market continues to evolve, it appears poised for sustained growth, with a focus on enhancing user experience and improving clinical outcomes.

Technological Advancements

The Diabetes Devices Market is witnessing rapid technological innovations, particularly in continuous glucose monitoring and insulin delivery systems. These advancements are enhancing the accuracy and convenience of diabetes management, allowing patients to monitor their glucose levels in real-time and adjust their insulin intake accordingly.

Integration of Digital Health Solutions

There is a notable trend towards the integration of digital health solutions within the Diabetes Devices Market. Mobile applications and telehealth services are increasingly being utilized to support diabetes management, providing patients with tools for tracking their health data and facilitating communication with healthcare providers.

Growing Patient Awareness

An increase in patient awareness regarding diabetes management is influencing the Diabetes Devices Market. Educational programs and resources are empowering individuals to take charge of their health, leading to a higher demand for innovative devices that support effective monitoring and treatment.

Diabetes Devices Market Market Drivers

Rising Prevalence of Diabetes

The increasing incidence of diabetes worldwide is a primary driver for the Diabetes Devices Market. According to recent statistics, the number of individuals diagnosed with diabetes has surged, with estimates suggesting that over 500 million people are currently living with the condition. This alarming trend necessitates the adoption of advanced diabetes management devices, including continuous glucose monitors and insulin pumps. As the prevalence of diabetes escalates, healthcare systems are compelled to invest in innovative solutions to enhance patient outcomes. Consequently, the demand for diabetes devices is expected to grow, as patients seek effective tools to manage their condition and healthcare providers aim to improve care delivery.

Government Initiatives and Funding

Government initiatives aimed at combating diabetes are influencing the Diabetes Devices Market positively. Various countries have implemented programs to promote diabetes awareness, prevention, and management. These initiatives often include funding for research and development of diabetes devices, as well as subsidies for patients to access necessary technologies. For example, some governments have introduced reimbursement policies for continuous glucose monitoring systems, making them more accessible to patients. Such supportive measures are expected to stimulate market growth, as they encourage innovation and increase the availability of advanced diabetes management tools.

Integration of Telehealth Services

The integration of telehealth services into diabetes management is emerging as a significant driver for the Diabetes Devices Market. Telehealth platforms facilitate remote monitoring and consultations, allowing healthcare providers to engage with patients more effectively. This trend is particularly beneficial for individuals with diabetes, as it enables timely interventions and personalized care plans. The market for telehealth services is expected to expand, with projections indicating a growth rate of approximately 25% annually. As patients increasingly embrace digital health solutions, the demand for compatible diabetes devices that can seamlessly integrate with telehealth platforms is likely to rise, further propelling the market.

Growing Demand for Personalized Medicine

The shift towards personalized medicine is becoming a pivotal driver in the Diabetes Devices Market. Patients are increasingly seeking tailored treatment options that cater to their unique health profiles. This trend is reflected in the rising demand for devices that offer personalized insights and recommendations based on individual glucose patterns. The market for personalized diabetes devices is anticipated to grow significantly, with estimates suggesting a potential increase of over 15% in the next few years. As healthcare providers focus on delivering customized care, the development of devices that integrate personalized data analytics will likely become a key factor in enhancing patient engagement and improving health outcomes.

Technological Innovations in Diabetes Management

Technological advancements play a crucial role in shaping the Diabetes Devices Market. Innovations such as artificial intelligence, machine learning, and advanced sensor technologies are revolutionizing diabetes management. For instance, the development of smart insulin pens and automated insulin delivery systems has transformed how patients manage their blood glucose levels. The market for diabetes devices is projected to witness substantial growth, with estimates indicating a compound annual growth rate of over 10% in the coming years. These innovations not only enhance the accuracy of glucose monitoring but also improve patient adherence to treatment regimens, thereby driving the demand for sophisticated diabetes management solutions.

Market Segment Insights

By Device Type: Blood Glucose Monitors (Largest) vs. Continuous Glucose Monitoring Systems (Fastest-Growing)

The Diabetes Devices Market shows a significant distribution of market share among its key segments. Blood Glucose Monitors hold the largest share, driving consumer preference due to their established presence and easy usability. Insulin Delivery Devices are also crucial, representing a substantial portion of the market, especially with the increasing reliance on insulin therapy. Continuous Glucose Monitoring Systems are gaining traction as a vital innovation, appealing to tech-savvy patients looking for more precise glucose tracking. Meanwhile, Diabetes Management Software supports these devices, enhancing user experience through integrated data management.

Blood Glucose Monitors (Dominant) vs. Continuous Glucose Monitoring Systems (Emerging)

Blood Glucose Monitors continue to dominate the Diabetes Devices Market, primarily due to their accessibility and familiarity among patients. These devices offer users the convenience of manual testing, appealing to those who prefer straightforward management of their diabetes. In contrast, Continuous Glucose Monitoring Systems are emerging as a pivotal element in diabetes management, providing real-time data to users. Their growth can be attributed to technological advancements, increasing awareness among patients, and a rising focus on proactive health management. As users seek more seamless integration of technology into their care routines, CGMs are becoming an essential choice, signifying a shift towards more dynamic and continuous diabetes management solutions.

By End User: Hospitals (Largest) vs. Homecare (Fastest-Growing)

In the Diabetes Devices Market, hospitals represent the largest share among end users, driven by their established infrastructure and resource availability for managing diabetes. This segment is crucial as it supports comprehensive patient care with advanced tools and technologies. Homecare, on the other hand, is experiencing rapid growth, influenced by increasing patient preferences for self-management and remote monitoring solutions.

Hospitals (Dominant) vs. Homecare (Emerging)

Hospitals serve as the dominant end user in the Diabetes Devices Market, benefiting from robust supply chains and specialized healthcare teams. This segment often employs high-end devices for continuous monitoring and advanced treatment options. In contrast, the homecare segment is emerging rapidly, focusing on user-friendly devices that facilitate self-management and enhance patient independence. The shift towards homecare is fueled by technological advancements in devices that offer connectivity, ease of use, and telehealth integration, catering to the lifestyle changes among diabetes patients who prefer to monitor their condition from home.

By Distribution Channel: Retail Pharmacies (Largest) vs. Online Pharmacies (Fastest-Growing)

In the Diabetes Devices Market, retail pharmacies hold the largest share among distribution channels due to their established presence and accessible locations for patients. They offer a wide range of diabetes devices, which ensures that consumers have reliable access to vital products. Online pharmacies are gaining momentum, appealing to a tech-savvy demographic that prioritizes convenience and home delivery, allowing them to capture a significant portion of the market.

Retail Pharmacies (Dominant) vs. Online Pharmacies (Emerging)

Retail pharmacies are a dominant force in the Diabetes Devices Market, providing patients with immediate access to necessary products, supported by knowledgeable staff who can assist with any inquiries. Their brick-and-mortar presence also allows for physical consultations, which is invaluable for new patients learning to manage their diabetes. On the other hand, online pharmacies represent an emerging segment, capturing the interest of consumers who appreciate the convenience of online shopping. The trend towards digital health and the growing adoption of telemedicine services further bolster the case for online pharmacies as a vital alternative, making them significant competitors in the marketplace.

By Application: Type 2 Diabetes (Largest) vs. Type 1 Diabetes (Fastest-Growing)

In the Diabetes Devices Market, the application segment is predominantly driven by Type 2 Diabetes, representing the largest share due to the increasing prevalence among adults. This condition requires ongoing management, which has led to a higher demand for innovative diabetes management devices. Type 1 Diabetes also holds a significant position, but it is Type 2 Diabetes that leads in volume, fueled by an aging population and rising rates of obesity. The growth trends in this segment are notably influenced by advancements in technology that enhance patient care. Type 1 Diabetes is the fastest-growing segment, attributed to increased awareness and improved diagnostic practices. Additionally, the provision of continuous glucose monitoring devices and integrated insulin delivery systems is catalyzing the development of devices tailored for both Type 1 and Type 2 Diabetes patients, influencing their adoption in the market.

Type 2 Diabetes: Dominant vs. Type 1 Diabetes: Emerging

Type 2 Diabetes remains the dominant application in the diabetes devices market, reflecting the highest prevalence and a robust demand for management solutions. The ease of use and accessibility of devices specifically designed for Type 2 Diabetes patients contribute to their widespread adoption. In contrast, Type 1 Diabetes, while historically viewed as the less prevalent condition, is emerging rapidly within the market due to a rise in the diagnosed cases and advancements in wearable technologies. Continuous glucose monitors tailored for Type 1 patients are gaining traction, supported by a growing base of young patients who are tech-savvy and prefer innovative solutions. This dynamic is causing a shift as newer products are developed to meet the unique needs of Type 1 Diabetes, enhancing their market position.

Get more detailed insights about Diabetes Devices Market Research Report - Forecast Till 2035

Regional Insights

North America : Market Leader in Innovation

North America is the largest market for diabetes devices, holding approximately 45% of the global share. The region benefits from advanced healthcare infrastructure, high prevalence of diabetes, and significant investments in research and development. Regulatory support from agencies like the FDA further catalyzes market growth, ensuring rapid approval of innovative devices. The increasing adoption of continuous glucose monitoring systems and insulin delivery devices is driving demand. The United States is the primary contributor to this market, with key players such as Medtronic, Abbott, and Dexcom leading the charge. The competitive landscape is characterized by continuous innovation and strategic partnerships among these companies. The presence of a well-established distribution network and a growing focus on personalized diabetes management solutions are also pivotal in shaping the market dynamics.

Europe : Emerging Market with Growth Potential

Europe is the second-largest market for diabetes devices, accounting for around 30% of the global market share. The region is witnessing a surge in diabetes prevalence, driven by lifestyle changes and an aging population. Regulatory frameworks, such as the EU Medical Device Regulation, are enhancing product safety and efficacy, thereby boosting consumer confidence. The increasing focus on preventive healthcare and digital health solutions is also propelling market growth. Leading countries in this region include Germany, France, and the UK, where companies like Roche and Boehringer Ingelheim are prominent. The competitive landscape is marked by a mix of established players and innovative startups, fostering a dynamic environment for product development. Collaborations between healthcare providers and technology firms are further enhancing the availability of advanced diabetes management solutions.

Asia-Pacific : Rapidly Growing Market

Asia-Pacific is an emerging powerhouse in the diabetes devices market, holding approximately 20% of the global share. The region is experiencing a rapid increase in diabetes cases, driven by urbanization, dietary changes, and sedentary lifestyles. Government initiatives aimed at improving healthcare access and affordability are also contributing to market growth. The rising demand for affordable and effective diabetes management solutions is a key driver in this region. Countries like China and India are leading the charge, with significant investments in healthcare infrastructure. The competitive landscape features both multinational corporations and local manufacturers, creating a diverse market environment. Key players such as Johnson & Johnson and Ascensia Diabetes Care are actively expanding their presence, focusing on innovative products tailored to local needs.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa represent a resource-rich frontier for the diabetes devices market, holding about 5% of the global share. The region faces a rising diabetes prevalence, driven by lifestyle changes and urbanization. Government initiatives aimed at improving healthcare access and awareness are crucial for market growth. The increasing focus on chronic disease management and the introduction of health insurance schemes are also expected to drive demand for diabetes devices. Leading countries include South Africa and the UAE, where healthcare investments are on the rise. The competitive landscape is characterized by a mix of international and local players, with companies like AstraZeneca and Insulet making significant inroads. The region's unique challenges, such as varying healthcare infrastructure, present both opportunities and hurdles for market expansion.

Key Players and Competitive Insights

The Diabetes Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of diabetes globally. Key players such as Medtronic (US), Abbott (US), and Dexcom (US) are at the forefront, each adopting distinct strategies to enhance their market positioning. Medtronic (US) focuses on innovation through continuous product development, particularly in insulin delivery systems, while Abbott (US) emphasizes its FreeStyle Libre continuous glucose monitoring (CGM) system, which has gained significant traction due to its user-friendly design. Dexcom (US) is also notable for its commitment to digital health solutions, integrating data analytics to improve patient outcomes. Collectively, these strategies foster a competitive environment that prioritizes technological innovation and patient-centric solutions.

In terms of business tactics, companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. The market structure appears moderately fragmented, with several players vying for market share, yet dominated by a few key companies that wield substantial influence. This competitive structure allows for a diverse range of products and services, catering to varying patient needs and preferences.

In August 2025, Abbott (US) announced a strategic partnership with a leading telehealth provider to enhance remote patient monitoring capabilities. This collaboration is poised to expand Abbott's reach in the digital health space, allowing for more integrated diabetes management solutions. The significance of this move lies in its potential to improve patient engagement and adherence to treatment plans, thereby enhancing overall health outcomes.

In September 2025, Medtronic (US) launched a new version of its insulin pump, featuring advanced algorithms for automated insulin delivery. This innovation is critical as it positions Medtronic to capture a larger share of the market by appealing to tech-savvy patients seeking more efficient diabetes management solutions. The introduction of this product underscores Medtronic's commitment to leveraging technology to improve patient care.

In October 2025, Dexcom (US) unveiled a new software update for its CGM systems, incorporating artificial intelligence to provide personalized insights for users. This development reflects a broader trend towards AI integration in diabetes management, suggesting that Dexcom is keen on enhancing user experience and fostering better health outcomes through data-driven insights. The strategic importance of this update lies in its potential to differentiate Dexcom in a competitive market increasingly focused on personalized healthcare solutions.

As of October 2025, current competitive trends in the Diabetes Devices Market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, enabling companies to leverage complementary strengths and enhance their product offerings. Looking ahead, it appears that competitive differentiation will increasingly pivot from price-based strategies to innovation, technological advancements, and the reliability of supply chains. This shift may redefine how companies engage with patients and healthcare providers, ultimately shaping the future landscape of diabetes management.

Key Companies in the Diabetes Devices Market market include

Industry Developments

Recent developments in the Diabetes Devices Market highlight significant advancements and partnerships among top companies. In September 2023, Medtronic announced enhancements in their continuous glucose monitoring systems, aiming to provide users with improved data accuracy and real-time insights.

Abbott Laboratories has launched new features for their FreeStyle Libre system, further solidifying their leadership in the sector. In October 2023, Dexcom revealed its partnership with Ascensia Diabetes Care to integrate their technologies, enhancing user experience through app connectivity. The market valuation for diabetes devices has reached an impressive milestone, driven by rising global diabetes prevalence and the increasing adoption of smart devices, demonstrating a strong growth trajectory in the next few years.

.webp

Future Outlook

Diabetes Devices Market Future Outlook

The Diabetes Devices Market is projected to grow at a 7.8% CAGR from 2024 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising healthcare expenditure.

New opportunities lie in:

Development of integrated diabetes management platformsExpansion of <a href="https://www.marketresearchfuture.com/reports/telehealth-market-900">telehealth</a> services for remote monitoringInvestment in AI-driven predictive analytics for personalized care

By 2035, the market is expected to be robust, driven by innovation and increased demand.

Market Segmentation

Diabetes Devices Market End User Outlook

Hospitals
Homecare
Diabetes Clinics
Ambulatory Surgical Centers

Diabetes Devices Market Application Outlook

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes

Diabetes Devices Market Device Type Outlook

Blood Glucose Monitors
Insulin Delivery Devices
Continuous Glucose Monitoring Systems
Diabetes Management Software

Diabetes Devices Market Distribution Channel Outlook

Online Pharmacies
Retail Pharmacies
Hospital Pharmacies
Direct Sales

Report Scope

MARKET SIZE 2024	32.88(USD Billion)
MARKET SIZE 2025	35.44(USD Billion)
MARKET SIZE 2035	75.13(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	7.8% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Market analysis in progress
Segments Covered	Market segmentation analysis in progress
Key Market Opportunities	Integration of artificial intelligence in diabetes management devices enhances patient outcomes and operational efficiency.
Key Market Dynamics	Technological advancements and regulatory changes drive innovation and competition in the Diabetes Devices Market.
Countries Covered	North America, Europe, APAC, South America, MEA